Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

Paxlovid is the most commonly prescribed at home treatment for COVID-19 in the U.S. It is approved to treat COVID in adults who are at risk of severe complications from the illness.

COVID-19 cases are rising in 26 states. Is the US in a summer wave? What to know about COVID trends and symptoms of the new ...

WHAT TO KNOW The antiviral drug Paxlovid dramatically reduces the chance of death and hospitalization for people at high risk of severe COVID-19, but uptake is low, studies have found. Experts say ...

According to Lokant, if you have COVID and notice certain concerning symptoms, such as difficulty breathing, chest pain or ...

Those results are a blow to the millions of people living with the condition, which currently has no approved treatment or cure. Paxlovid has long been a source of hope for those with Long COVID.

While researchers found a 15-day course of Paxlovid proved safe as an extended-duration treatment — it's typically prescribed for only five days — the drug failed to lessen the symptoms ...

Paxlovid made no significant improvement to long COVID symptoms, including fatigue, brain fog and body aches. The finding “does not rule out” Paxlovid as a therapy, the researchers wrote.

People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.

As Texas and the majority of the country experience a surge in COVID-19 cases, more people testing positive might be seeking out relief through treatment drugs like Paxlovid.